The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines-Reference-Cited by-同舟云学术

The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines

Published:2011-05 Issue:3 Volume:27 Page:S1-S59
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Bell Alan D.,Roussin André,Cartier Raymond,Chan Wee Shian,Douketis James D.,Gupta Anil,Kraw Maria E.,Lindsay Thomas F.,Love Michael P.,Pannu Neesh,Rabasa-Lhoret Rémi,Shuaib Ashfaq,Teal Philip,Théroux Pierre,Turpie Alexander G.G.,Welsh Robert C.,Tanguay Jean-François

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference361 articles.

1. Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes;Yan;Arch Intern Med,2007

2. Percutaneous coronary intervention vs coronary-artery bypass grafting for severe coronary artery disease;Serruys;N Engl J Med,2009

3. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis;Bhatt;JAMA,2006

4. Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease;Stafford;PLoS Med,2005

5. Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease—executive summary;Abramson;Can J Cardiol,2005

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management strategies in persons with inherited haemophilia requiring antithrombotic therapy: A scoping review;Haemophilia;2023-12-12

2. Aspirin for the Primary Prevention of Vascular Ischemic Events: An Updated Systematic Review and Meta-analysis to Support Shared Decision-Making;CJC OPEN;2023

3. Aspirin for the Primary Prevention of Vascular Ischemic Events: An Updated Systematic Review and Meta-analysis to Support Shared Decision-Making;CJC Open;2023-12

4. Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention;CJC Open;2023-11

5. Direct Oral Anticoagulants use in Patients with Stable Coronary Artery Disease, Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention;Current Pharmaceutical Design;2023-10